Abstract | BACKGROUND: Exposure to intermittent hypoxia (IH) may enhance cardiac function and protects heart against ischemia-reperfusion (I/R) injury. To elucidate the underlying mechanisms, we developed a cardioprotective IH model that was characterized at hemodynamic, biochemical and molecular levels. METHODS: Mice were exposed to 4 daily IH cycles (each composed of 2-min at 6-8% O2 followed by 3-min reoxygenation for 5 times) for 14 days, with normoxic mice as controls. Mice were then anesthetized and subdivided in various subgroups for analysis of contractility (pressure-volume loop), morphology, biochemistry or resistance to I/R (30-min occlusion of the left anterior descending coronary artery (LAD) followed by reperfusion and measurement of the area at risk and infarct size). In some mice, the phosphatidylinositide 3-kinase (PI3K) inhibitor wortmannin was administered (24 µg/kg ip) 15 min before LAD. RESULTS: We found that IH did not induce myocardial hypertrophy; rather both contractility and cardiac function improved with greater number of capillaries per unit volume and greater expression of VEGF-R2, but not of VEGF. Besides increasing the phosphorylation of protein kinase B (Akt) and the endothelial isoform of NO synthase with respect to control, IH reduced the infarct size and post-LAD proteins carbonylation, index of oxidative damage. Administration of wortmannin reduced the level of Akt phosphorylation and worsened the infarct size. CONCLUSION: We conclude that the PI3K/Akt pathway is crucial for IH-induced cardioprotection and may represent a viable target to reduce myocardial I/R injury.
|
Authors | Giuseppina Milano, Provvidenza Maria Abruzzo, Alessandra Bolotta, Marina Marini, Laura Terraneo, Barbara Ravara, Luisa Gorza, Maurizio Vitadello, Sabrina Burattini, Davide Curzi, Elisabetta Falcieri, Ludwig K von Segesser, Michele Samaja |
Journal | PloS one
(PLoS One)
Vol. 8
Issue 10
Pg. e76659
( 2013)
ISSN: 1932-6203 [Electronic] United States |
PMID | 24124584
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Phosphatidylinositol 3-Kinases
- Vascular Endothelial Growth Factor Receptor-2
- Proto-Oncogene Proteins c-akt
|
Topics |
- Animals
- Hemodynamics
- Hypoxia
(metabolism)
- Male
- Mice
- Myocardial Contraction
- Myocardial Reperfusion Injury
(metabolism, physiopathology)
- Myocardium
(metabolism)
- Neovascularization, Physiologic
- Oxidative Stress
- Phosphatidylinositol 3-Kinases
(metabolism)
- Proto-Oncogene Proteins c-akt
(metabolism)
- Signal Transduction
- Vascular Endothelial Growth Factor Receptor-2
(metabolism)
|